Please use this identifier to cite or link to this item:
|Title:||Solubility, metastable zone width, and racemic characterization of propranolol hydrochloride||Authors:||Wang, X.
Gibbs free energy
Powder X-ray diffraction
Ternary solubility diagram
|Issue Date:||2002||Citation:||Wang, X., Wang, X.J., Ching, C.B. (2002). Solubility, metastable zone width, and racemic characterization of propranolol hydrochloride. Chirality 14 (4) : 318-324. ScholarBank@NUS Repository.||Abstract:||Characterization of the racemic species, which can be a racemic compound, a racemic conglomerate, or a pseudoracemate (solid solution), is a prerequisite for the design of crystallization resolution processes. It is useful to determine the solid/liquid equilibrium solubility of the enantiomer mixtures for crystallization operation. For the beta-blocker drug propranolol hydrochloride, Gibbs free energy of formation of racemic compound and entropy of mixing of the (R)- and (S)- enantiomers in the liquid state for racemic conglomerate were calculated. The structural differences between (R, S)-propranolol hydrochloride and its (S)-enantiomer were further investigated by powder X-ray diffraction patterns, infrared spectra, and solid-state NMR spectra. The solubility and metastable zone width of (R, S)- propranolol hydrochloride in a mixed solvent of methanol and acetone were determined by cooling crystallization over the temperature range 3.5-42.5°C. The ternary solubility diagram of (R)-, (S)propranolol hydrochloride was constructed using the same mixed solvent. The diagram will be useful as a guide for choosing crystallization operation conditions to produce pure enantiomers. © 2002 Wiley-Liss, Inc.||Source Title:||Chirality||URI:||http://scholarbank.nus.edu.sg/handle/10635/92341||ISSN:||08990042|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.